WATCH: Positioning for success—preparing for and managing patent disputes under Hatch-Waxman and the BPCIA

Denise Main, Partner at Finnegan, moderates a discussion with Shana Cyr, Executive Director and Head of Patent Litigation at Bristol Myers Squibb; Charlie Lou, IP Region Head, China at Takeda Pharmaceuticals; and Paul Browning, Partner at Finnegan.The panel outlines key strategic considerations for Hatch-Waxman litigation, emphasising the importance of timing, portfolio health, Orange Book positioning, and early regulatory planning. They also address the distinct scientific and regulatory challenges of preparing for biologics patent disputes under the BPCIA, including pre-litigation information exchange.The conversation provides practical approaches to managing the intense organisational demands of high-stakes patent litigation. The speakers share strategies for case assessment, resource planning, and fostering effective coordination between in-house and outside counsel to reduce risk and drive efficiency.